Reporting and transparency

(a) In general The Secretary of Health and Human Services (in this section referred to as the Secretary) shall, not later than 18 months after the date of enactment of this Act and annually for 5 years thereafter, submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report describing, in compliance with section 505G(d) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355h(d))— (1) the status of implementation of evidence and testing standards for nonprescription drugs intended for topical administration, including— (A) the application of evidence or testing standards made under section 505G(r) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355h) (as added by section 2); and (B) the number of sunscreen active ingredient requests reviewed using the standards under such section 505G(b); and (2) the progress of the Food and Drug Administration in allowing nonclinical testing alternatives to animal testing for the consideration of sunscreen active ingredients. (b) Publication Not later than 7 days after the date on which the Secretary submits a report under subsection (a), the Secretary shall publish such report on the website of the Food and Drug Administration.